Summary: A genetic marker linked to human Restless Legs Syndrome (RLS) is required for healthy cerebellar development. Researchers found that mutating the MEIS1 gene in zebrafish larvae disrupts the species’ rhythmic “burst and glide” locomotion, producing persistent, hyperactive movement episodes.
Neuroimaging and cellular analysis localized this abnormal behavior to a partial loss of Purkinje cells—key inhibitory neurons in the cerebellum that coordinate movement. Medications used to treat human RLS reversed the fish’s abnormal locomotion, providing the first mechanistic evidence that an RLS risk gene can disrupt motor circuits and suggesting the cerebellum as an important target for further clinical study.
Key Facts
- RLS mechanisms clarified: Restless Legs Syndrome affects millions, but objective biomarkers and clear neurobiological explanations have been limited. This study links a genetic risk factor to a concrete neural mechanism.
- Behavioral shift in zebrafish: Zebrafish lacking functional MEIS1 lose their typical “burst and glide” swimming pattern and instead exhibit prolonged, continuous movement bursts consistent with hyperactivity.
- Purkinje cell loss: MEIS1 deficiency disrupts cerebellar development and causes partial degeneration of Purkinje cells, the cerebellum’s principal inhibitory output neurons.
- Disinhibition of motor circuits: Reduced Purkinje cell inhibition allows downstream motor pathways to over-fire, translating internal circuit imbalance into abnormal locomotion.
- Pharmacological validation: Clinically used RLS medications normalized the mutant fish’s locomotor patterns, demonstrating translational relevance of the model.
Source: University of Basel
Restless legs, restless nights: Restless Legs Syndrome (RLS) is a widespread but still incompletely understood sleep disorder. Using larval zebrafish, a research team at the University of Basel shows that a gene associated with RLS is essential for cerebellar development and motor control, offering new clues about the disorder’s biological basis.
RLS causes an irresistible urge to move the legs or other body parts, often accompanied by uncomfortable sensations that appear or worsen at night or during rest. Although common, the condition’s underlying biological causes have been difficult to pin down.
Led by Professor Alex Schier at the Biozentrum of the University of Basel, the team turned to larval zebrafish for their transparent brains and quantifiable movement patterns. These features allowed the researchers to pair genetic manipulations with high-resolution behavioral and neural readouts.
“Human studies have implicated multiple brain regions in RLS, but how those regions contribute to symptoms has been unclear,” says Schier. “Our findings highlight the cerebellum as a region that can shape movement-related aspects of the disorder.”
Genes and sleep-related movement disorders
The broader project aimed to map genetic contributors to sleep-related movement disorders, including RLS. Previous human genetic studies identified several candidate genes, yet their neuronal roles were not well defined, explains Dr. William Joo, first author of the study.
Zebrafish with altered movement patterns
Among several genes examined, MEIS1 produced the clearest phenotype. Wild-type zebrafish larvae show a characteristic “burst and glide” swimming behavior—brief swimming bouts followed by pauses. In MEIS1 mutants, movement bouts lengthened substantially and pauses shortened, producing sustained, hyperactive locomotion.
This behavioral change led the team to examine brain structure and function. They found developmental abnormalities concentrated in the cerebellum, with a notable reduction in Purkinje cells, the principal inhibitory neurons that regulate downstream motor circuits.
The cerebellum in focus
Purkinje cells release inhibitory neurotransmitters to temper activity in motor pathways, acting like a neural braking system. Partial loss of these cells in MEIS1 mutants weakened that brake, allowing overactivity in downstream neurons and producing the abnormal locomotor patterns observed.
Importantly, the investigators administered medications commonly prescribed for human RLS to the mutant larvae. These treatments restored more normal activity patterns, supporting a shared pharmacological mechanism between the zebrafish model and human RLS.
Implications for therapies and diagnosis
This work is among the first to demonstrate a direct mechanistic link between an RLS-associated gene and altered brain development that produces abnormal motor behavior. The results suggest that other RLS risk genes could similarly affect cerebellar circuits.
While zebrafish provide a tractable platform for dissecting gene-to-circuit relationships, further research is needed to confirm whether the same cerebellar mechanisms operate in human patients. Still, these findings may guide future efforts to develop objective biomarkers and targeted treatments for RLS, which are currently diagnosed mainly by clinical symptoms.
Key Questions Answered:
A: Despite anatomical differences, zebrafish share conserved genes and core nervous system architecture with mammals. Larval zebrafish display a clear and quantifiable “burst and glide” locomotor pattern governed by basic motor-coordination circuits, making it straightforward to detect how specific genetic changes affect movement and neural activity.
A: Purkinje cells are the cerebellum’s primary output neurons and provide inhibitory control over downstream motor circuits. They act like a braking mechanism for movement. When MEIS1 mutations reduce Purkinje cell numbers or function, inhibitory control diminishes and downstream neurons can become overactive, producing persistent, hyperactive motor behavior.
A: The team used pharmacological validation: drugs effective in treating human RLS normalized the hyperactive movement in MEIS1 mutant larvae. This pharmacological rescue supports shared neurochemical pathways between the model and human RLS and strengthens the model’s translational value.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by staff.
About this genetics and neurology research news
Author: Angelika Jacobs
Source: University of Basel
Contact: Angelika Jacobs – University of Basel
Image: Image credit: Neuroscience News
Original Research: Open access. Disinhibition of cerebellar output by loss of Restless Legs Syndrome-associated gene MEIS1 by Joo W, Choi JW, Schier AF. DOI: 10.1016/j.cub.2026.05.043
Abstract
Disinhibition of cerebellar output by loss of Restless Legs Syndrome-associated gene MEIS1
Genome-wide association studies have identified risk variants for restless legs syndrome (RLS), but the behavioral functions and sites of action of the corresponding genes remain unknown.
Here, we analyzed zebrafish mutants for candidate RLS genes and found that meis1b is required for normal locomotor behavior and cerebellar development.
Neuronal manipulation experiments indicated that loss of meis1b perturbs locomotor behavior by generating abnormal cerebellar output—a mechanism reminiscent of movement disorders such as ataxia and dystonia.